Lantheus Medical Imaging Announces FDA Approval of Jubilant HollisterStier as a New Manufacturing Site for NEUROLITE® Read more about Lantheus Medical Imaging Announces FDA Approval of Jubilant HollisterStier as a New Manufacturing Site for NEUROLITE®
Lantheus Medical Imaging Announces Xenon 133 Supply Agreement with Institute for Radioelements Read more about Lantheus Medical Imaging Announces Xenon 133 Supply Agreement with Institute for Radioelements
Lantheus Medical Imaging Reports Third Quarter 2014 Financial Results Read more about Lantheus Medical Imaging Reports Third Quarter 2014 Financial Results
Lantheus to Host Third Quarter 2014 Earnings Conference Call on November 12, 2014 at 4:30 p.m. Eastern Time Read more about Lantheus to Host Third Quarter 2014 Earnings Conference Call on November 12, 2014 at 4:30 p.m. Eastern Time
Lantheus Medical Imaging and SHINE Medical Announce Mo-99 Supply Agreement Read more about Lantheus Medical Imaging and SHINE Medical Announce Mo-99 Supply Agreement
Lantheus Medical Imaging to Present Data on Novel PET Cardiac Imaging Agent Flurpiridaz F 18 at ASNC Annual Scientific Session Read more about Lantheus Medical Imaging to Present Data on Novel PET Cardiac Imaging Agent Flurpiridaz F 18 at ASNC Annual Scientific Session
Lantheus Medical Imaging to Present at Imperial Capital Global Opportunities Conference on September 18, 2014 Read more about Lantheus Medical Imaging to Present at Imperial Capital Global Opportunities Conference on September 18, 2014
Lantheus Medical Imaging Reports Results for Second Quarter Ended June 30, 2014 Read more about Lantheus Medical Imaging Reports Results for Second Quarter Ended June 30, 2014
Lantheus to Host Second Quarter 2014 Conference Call on August 12, 2014 at 4:30 p.m. Eastern Time Read more about Lantheus to Host Second Quarter 2014 Conference Call on August 12, 2014 at 4:30 p.m. Eastern Time
Lantheus Holdings, Inc. Announces Filing of Registration Statement for Proposed Initial Public Offering Read more about Lantheus Holdings, Inc. Announces Filing of Registration Statement for Proposed Initial Public Offering
